” Even though the Ricaurte story was unfolding, MAPS at last obtained FDA sign-off on a protocol for human trials of MDMA to be a remedy for PTSD, but only just after it ordered a $one million insurance policy coverage to indemnify the critique board.The potential risk of ecstasy deaths boosts in incredibly hot environments which include crowded